CCP
SGEN

Corient Capital Partners’s Seagen Inc. Common Stock SGEN Stock Holding History

Corient Capital Partners’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$483K Buy
2,728
+53
+2% +$8.63K 0.04% 346
2022
Q2 		$474K Buy
2,675
+522
+24% +$75.2K 0.04% 357
2022
Q1 		$310K Buy
2,153
+73
+4% +$9.88K 0.02% 530
2021
Q4 		$322K Buy
2,080
+135
+7% +$22.6K 0.02% 494
2021
Q3 		$330K Buy
1,945
+121
+7% +$18.8K 0.02% 466
2021
Q2 		$288K Buy
1,824
+131
+8% +$19.5K 0.02% 496
2021
Q1 		$235K Buy
1,693
+283
+20% +$45.6K 0.02% 524
2020
Q4 		$247K Buy
1,410
+86
+6% +$16K 0.02% 428
2020
Q3 		$259K Sell
1,324
-31
-2% -$5.19K 0.03% 376
2020
Q2 		$230K Buy
+1,355
New +$202K 0.03% 401

Other funds holding SGEN

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Corient Capital Partners's SGEN Position: Q3 2022 in Review

Corient Capital Partners increased its Seagen Inc. Common Stock (SGEN) stake by 2% in Q3 2022, buying an estimated $8.63K and bringing the position to 2,728 shares worth $483K. The position accounts for 0.04% of the portfolio, ranked #346.

Corient Capital Partners first reported a position in SGEN in Q2 2020 and has held it in 10 quarters since. 539 funds tracked by Wall St. Rank hold SGEN as of Q3 2022.

  • Corient Capital Partners held 2,728 shares of Seagen Inc. Common Stock worth $483K as of Q3 2022.
  • Corient Capital Partners bought 53 Seagen Inc. Common Stock shares in Q3 2022, an estimated $8.63K.
  • Seagen Inc. Common Stock made up 0.04% of Corient Capital Partners's portfolio in Q3 2022, its #346 holding.
  • Corient Capital Partners first reported a position in Seagen Inc. Common Stock in Q2 2020 and has held it in 10 quarters since.
  • 539 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.